High cut-off hemodialysis and bortezomib-based therapy to rescue kidneys in myeloma-dependent cast nephropathy

American Journal of Hematology

Volumn 87, Issue 6, 2012, Pages 640-

  Sinisalo, Marjatta ^a   Silvennoinen, Raija ^a   Wirta, Ole ^a  

^a TAMPERE UNIVERSITY HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

BORTEZOMIB;

ADULT; AGED; CANCER CHEMOTHERAPY; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); FEMALE; FREE LIGHT CHAIN; HEMODIALYSIS; HIGH CUT OFF HEMODIALYSIS; HUMAN; KIDNEY DISEASE; KIDNEY FUNCTION; LETTER; LIGHT CHAIN; MALE; MYELOMA; MYELOMA DEPENDENT CAST NEPHROPATHY; PRIORITY JOURNAL;

ACUTE KIDNEY INJURY; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; BORONIC ACIDS; COMBINED MODALITY THERAPY; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIPLE MYELOMA; PROTEASE INHIBITORS; PYRAZINES; RENAL DIALYSIS; STEM CELL TRANSPLANTATION; TRANSPLANTATION, AUTOLOGOUS; TREATMENT OUTCOME;

EID: 84861343329     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.23189     Document Type: Letter

References (5)

1. Clark WF, Stewart AK, Rock GA, et al. Plasma exchange when myeloma presents as acute renal failure: A randomized, controlled trial. Ann Intern Med 2005; 143: 777-84.
2. Burnette BL, Leung N, Rajkumar SV. Renal improvement in myeloma with bortezomib plus plasma exchange. N Engl J Med 2011; 364: 2365-2366.
3. Wirk B. Renal failure in multiple myeloma: A medical emergency. Bone Marrow Transplantation 2011; 46: 771-783.
4. Basnayake K, Hutchison C, Kamel D, et al. Resolution of cast nephropathy following free light chain removal by haemodialysis in a patient with myeloma multiple. A case report. J Med Case Reports 2008; 2: 380.
5. Hutchison CA, Cook M, Heyne N, et al. European trial of free light chain removal by extended haemodialysis in cast nephropathy (EuLITE). A randomized control trial. Trials 2008; 9: 55.